<SEC-DOCUMENT>9999999995-21-001079-index.html : 20210324
<SEC-HEADER>9999999995-21-001079.hdr.sgml : 20210324
<ACCEPTANCE-DATETIME>20210324001520
ACCESSION NUMBER:		9999999995-21-001079
CONFORMED SUBMISSION TYPE:	EFFECT
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20210323
DATE AS OF CHANGE:		20210324
EFFECTIVENESS DATE:		20210323

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akers Biosciences, Inc.
		CENTRAL INDEX KEY:			0001321834
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		EFFECT
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-252181
		FILM NUMBER:		21766461

	BUSINESS ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036
		BUSINESS PHONE:		856-848-8698

	MAIL ADDRESS:	
		STREET 1:		1185 AVENUE OF THE AMERICAS
		STREET 2:		3RD FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10036

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Akers Biosciences Inc
		DATE OF NAME CHANGE:	20050325
</SEC-HEADER>
<DOCUMENT>
<TYPE>EFFECT
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>